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 Abstract. Cyclobenzaprine (CBP) is a centrally acting muscle relaxant 
whose myriad of therapeutic applications imply the need of better 
understanding its pharmacokinetics and thermodynamics. Henceforth, 
this work was concerned with an in silico investigation of CBP main 
metabolizers in the human organism, namely CYP1A2 and CYP3A4. For 
this purpose, computational methods were employed, such as molecular 
docking and other semi-empirical approaches. Results evidenced that the 
model herein depicted for CBP-CYP1A2 may not reproducibly represent 
the physiological interaction between CBP and this enzyme. Moreover, 
CBP-CYP3A4 docking results evidence thermodynamic feasibility of the 
molecular docking model and were further corroborated by literature, 
what may reproducibly represent a possible interaction between CBP and 
this macromolecule. 
Keywords: tricyclic; cheminformatics; redox enzymes; metabolism; 
pharmacokinesis. 
 
 
 
INTRODUCTION 
Cyclobenzaprine (CBP) is a centrally acting mus-
cle relaxant whose applicability range from treat-
ing acute musculoskeletal pain to chronic condi-
tions such as fibromyalgia. The structure of this 
compound is quite similar to that of tricyclic an-
tidepressants, which implies the possibility of yet 
unknown therapeutic uses. Albeit CBP metabo-
lism has been studied under the light of different 
methods over the years, the thermodynamics 
and kinetics of its molecular docking interactions 
in the context of xenobiotic metabolism are yet 
unknown [4, 5, 22, 24]. 
CBP metabolism is primarily mediated by P450-
family cytochromes (CYP), more specifically 
CYP1A2 and CYP3A4, what implies that the asso-
ciation of this muscle relaxant with other drugs 
primarily metabolized by these CYP isoforms 
might result in important interactions, which 
could henceforth affect patient safety. Although 
the enzymes responsible for CBP metabolism 
have been identified, there were, to the best of 
our knowledge, no studies regarding the ther-
modynamics of CBP-CYP interaction [17, 19, 20, 
23]. 
Regarding molecular docking strategies, pro-
grams such as AutoDock Vina allows fast scoring 
function set up as well as quick calculations, what 
is optimal in preliminary screenings for pharma-
codynamical prediction as well as medicinal 
chemistry studies. Furthermore, the concomitant 
employment of semi-empirical approaches to 
minimize the energy of complex chemical com-
pounds, further increase the appeal of computa-
tional chemistry in investigations concerning 
drug-receptor interactions [1, 6, 7]. 
In view of the importance of better understand-
ing CBP metabolism as well as the thermody-
namics of its docking with the major metaboliz-
ers (CYP1A2 and CYP3A4), this work is intended 
to employ cheminformatics tools to establish a 
semi-flexible docking model of CBP-CYP interac-
tion. Henceforth, CBP structure had its energy 
minimized through molecular mechanic func-
tions and was subjected to docking studies as a 
flexible ligand to interact with a rigid macro-
molecule i.e. CYP. 
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METHODS 
CBP (dimethyl(3-{tricyclo[9.4.0.0³,⁸]pentadeca-
1(15),3,5,7,9,11,13-heptaen-2-ylidene}propyl)amine) 
structure was minimized through Chimera soft-
ware version 1.13 coupled to Molecular Modeling 
Toolkit (MMTK) and AMBER toolkit 4.0 prior 
docking studies. The same software was used to 
edit protein units retrieved from Protein Data-
Bank (PDB). Moreover, the software Phyton Mo-
lecular Viewer (PMV) version 1.5.6 was used to 
evaluate torsion-prone regions in CBP molecule, 
and the docking models were conducted using 
AutoDock Vina and AutoDock Tools version 1.5.6. 
The docking model herein employed is based on 
a flexible ligand and a rigid receptor, therefore 
configuring itself in a semi-flexible model [2, 16, 
18]. The minimization in energy conformation 
and HOMO surface calculations were performed 
employing the MM2 Force Field in Chem-
Draw3D®Pro 12. 
CYP1A2 (PDB entry: 2HI4) and CYP3A4 (PDB 
entry: 4NY4) were used in this study. 
Concerning intermolecular thermodynamics, 
Gibbs free energy values correlate to the maxi-
mum of reversible work feasible at a given sys-
tem. In this context, it can be related to the inter-
action proneness between two molecules in a 
docking model. This parameter can be calculated 
through the following equation (1): 
ln iG RT K  ,     (1) 
where ΔG is the interaction affinity; R is the gas 
constant and T is the temperature.  
 
The equation (1) can be derived into order to 
yield the interaction constant iK . 
G
RT
iK e

 ,      (2) 
where e is the Euler’s number. 
 
RESULTS AND DISCUSSION 
In order to prepare CBP molecule for docking, 
CBP energy was minimized henceforth rendering 
the lowest energy conformer. Moreover, the 
highest occupied molecular orbital (HOMO) re-
gions were also calculated as well as the torsion-
feasible regions. Results are displayed in Fig-
ure 1. 
 
 
Figure 1 – Results of CBP energy minimization 
 
Notes: A) Chemical structure of CBP lowest energy conformer evidencing a vinylic bridge (Vin) and the terminal 
aliphatic chain (AC). B) HOMO depictions of CBP lowest energy conformer depicting low (Blue) and high (Red) 
electron density regions. AC region correlates to HOMO-1 whereas Vin correlates to HOMO.  
All data gathered through Chimera software version 1.13. 
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Results evidenced that CBP lowest energy con-
former tricyclic ring does display a slight distor-
tion in the vinyl moiety (Vin) towards the same 
plane of the terminal aliphatic chain (AC), which 
grants the molecule a bent shape (Figure 1A). 
Moreover, HOMO regions of the molecule evi-
dence that there are two sites of elevated elec-
tron density in CBP, namely the Vin moiety and 
the tri-substituted amine in the AC. Further 
analysis evidenced that these moieties correlate 
to HOMO-1 and HOMO in Vin and AC, respec-
tively (Figure 1B). Concerning torsion-prone re-
gions, CBP AC is the sole moiety capable of rota-
tion hence it is based on σsp3-sp3 covalent bonds. 
A molecular docking study was undergone to 
analyze CBP interaction with CYP1A2. Hence-
forth the gridline for the docking study was set 
around the protoporphyrin ring of CYP1A2 
molecule employing high exhaustiveness, which 
was set to 20. Figure 2 displays the highest scor-
ing model with the distances between CBP, 
nearby residues and the iron moiety in the pro-
toporphyrin ring system measured in ang-
stroms (Å). 
 
 
Figure 2 – Docking depiction of the highest scoring model for CBP-CYP1A2 interaction 
 
Notes: NDistances therein highlighted between CBP molecule (Blue) and nearby residues as well as to the iron 
moiety of the protoporphiric group (orange sphere). All data gathered through Chimera software version 1.13. 
 
CBP highest scoring docking models presented 
no hydrogen bonds, albeit dipole interactions 
were seen (Figure 2A), which is a common oc-
currence in docking models [8, 9, 10]. However, 
the distance between CBP and the iron moiety in 
the protoporphyrin ring is nonetheless too dis-
tant to seemingly promote catalysis (19.5 Å). In 
this context, the model herein presented for CBP-
CYP1A2 interaction may not be able to efficiently 
correlate itself with experimental data reported 
in the literature [11, 12, 15, 25]. 
Although some models scored below the best 
presented additional hydrogen bonds, which are 
usually responsible for thermodynamic stable 
interactions between molecules, non-specific di-
pole interactions; molecular packaging and steric 
hindrance may generate false positives in dock-
ing models [3, 13, 14, 21]. Given that the pros-
thetic group of the macromolecule herein con-
cerned is intimately involved in reactional steps, 
the model; although thermodynamic feasible, 
may not be reproducible [12, 15]. 
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CBP interactions with CYP3A4 were also evalu-
ated through a molecular docking. Henceforth 
the gridline for the docking study was again set 
around the protoporphyrin ring; this time; of the 
CYP3A4 molecule. Furthermore, exhaustiveness 
was set to 20. Figure 3 displays the highest scor-
ing model with the distances between CBP and 
the iron moiety in the protoporphyrin ring sys-
tem measured in angstroms (Å). 
 
 
Figure 3 – Docking depiction of the highest scoring model for CBP-CYP3A4 interaction 
 
Notes: Distances therein highlighted between CBP molecule (Blue) and the iron moiety of the protoporphiric 
group (orange sphere). All data gathered through Chimera software version 1.13. 
 
Results evidenced that the highest scoring model 
presented optimal thermodynamic properties, 
and the distance between CBP and the iron moi-
ety in the protoporphyrin ring system (9.0 Å) 
was nonetheless inferior to the one observed in 
the model above-displayed for CBP-CYP1A2 in-
teraction (Figure 3A and 3B). 
Literature reports that CYP catalytic properties 
are attributed to the protoporphyrin ring which 
is chelated to an iron unit. This moiety is the 
main prosthetic group of P450 enzymes, and the 
condensed pyrrole aromatic nuclei associated to 
the transition metal; which is itself a lewis acid; 
enhances henceforth the redox capabilities of 
these catalytic biomolecules. This effect is caused 
by the dislodgement of electrons from the ligand 
towards CYP–prosthetic group, what nonetheless 
further justifies the model herein depicted since 
the interacting molecule should be in close prox-
imity to the prosthetic group for this process to 
happen [12, 15]. 
Equations (1) and (2) cited in the methods sec-
tion were employed to calculate iK  of the high-
est ranking docking models for CBP interaction 
with CYP1A2 and CYP3A4. Results are displayed 
in Table 1. 
Results evidenced that Ki for CYP3A4 macro-
molecule interaction with CBP was higher than 
that of CBP-CYP1A2 interaction. These findings 
suggest therefore that both G  and iK  values 
corroborate to higher thermodynamic feasibility 
of the CBP-CYP3A4 pose herein studied. 
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Table 1 – Thermodynamic properties calculated for the lowest energy conformation in the docking of CBP-
CYP1A2 and CBP-CYP3A4 
Receptor Affinity 
(kcal.mol
-1
) 
Binding Constant 
(cal.mol
-1
.K
-1
) 
RMSD 
l.b. 
RMSB 
u.b. 
HBonds 
(ligand) 
HBonds 
(receptor) 
CYP1A2 -8.0 0.9866 0.0 0.0 0 0 
CYP3A4 -8.8 0.9853 0.0 0.0 0 0 
 
CONCLUSION 
This work presented a study regarding CBP in-
teraction with CYP1A2 and CYP3A4. Results evi-
denced that the model herein depicted for CBP-
CYP1A2 may not reproducibly represent the 
physiological interaction between CBP and this 
enzyme. Moreover, CBP-CYP3A4 results from 
evidence thermodynamical feasibility of the mo-
lecular docking model and were further corrobo-
rated by literature, what may reproducibly rep-
resent a possible interaction between CBP and 
this macromolecule. 
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